Seeing Is Believing
Currently out of the existing stock ratings of Sarah James, 77 are a HOLD (22.65%), 251 are a BUY (73.82%), 12 are a SELL (3.53%).
Analyst Sarah James, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 59.95% that have a potential upside of 26.76% achieved within 245 days.
Sarah James’s has documented 669 price targets and ratings displayed on 32 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CNC, Centene Corp at 28-Jul-2025.
Analyst best performing recommendations are on CYH (COMMUNITY HEALTH SYSTEMS).
The best stock recommendation documented was for LFMD (LIFEMD) at 3/12/2024. The price target of $11 was fulfilled within 8 days with a profit of $2.62 (31.26%) receiving and performance score of 39.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$43
$17.74 (70.23%)
$51
18 days ago
(28-Jul-2025)
13/21 (61.9%)
$16.14 (60.09%)
301
Buy
$35
$9.74 (38.56%)
$42
18 days ago
(28-Jul-2025)
6/10 (60%)
$8.14 (30.31%)
554
Buy
$38
$12.74 (50.44%)
$65
18 days ago
(28-Jul-2025)
16/29 (55.17%)
$11.14 (41.47%)
562
Hold
$30
$4.74 (18.76%)
$52
30 days ago
(16-Jul-2025)
4/6 (66.67%)
$-0.41 (-1.35%)
107
Hold
$40
$14.74 (58.35%)
$71
1 months 4 days ago
(11-Jul-2025)
9/12 (75%)
$8.56 (27.23%)
87
Which stock is Sarah James is most bullish on?
Which stock is Sarah James is most reserved on?
What Year was the first public recommendation made by Sarah James?